QA: Elevance Health Inc in us_non_life/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001156039_2026_Elevance_Health_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 89.75888787602553, 'aggregate_val': 199125000000, 'exp_sum': 2194000000, 'exp_to_value': {'PremiumsEarned': 0, 'InvestmentIncome': 2194000000, 'InsuranceCommissionsAndFees': 0, 'remainder_Revenues': 0}}

Graph

Absolute values for 0001156039, Elevance Health Inc

  xvar xval
0 Investments 0
1 SeparateAccountAssets 0
2 PremiumsReceivable 10,073,000,000
3 DeferredPolicyAcquisitionCosts 0
4 ReinsuranceRecoverables 0
5 IntangibleAssets 39,544,000,000
6 AssetsCurrent 63,001,000,000
7 AssetsNonCurrent 4,679,000,000
8 remainder_Assets 4,197,000,000
9 LiabilityForClaimsAndClaimsAdjustmentExpense 17,229,000,000
10 PolicyholderContractDeposits 3,632,000,000
11 LiabilitiesCurrent 41,035,000,000
12 UnearnedPremiums 1,493,000,000
13 ReinsurancePayable 0
14 LongTermDebt 34,178,000,000
15 remainder_Liabilities -20,099,000,000
16 PolicyholderBenefitsAndClaims 153,057,222,443
17 SellingGeneralAndAdministrativeExpense 42,506,252,300
18 DeferredPolicyAcquisitionCostAmortizationExpense 0
19 remainder_Expenses 3,205,984,721
20 PremiumsEarned 0
21 InvestmentIncome 2,215,320,082
22 InsuranceCommissionsAndFees 0
23 remainder_Revenues 204,313,545,882
24 Revenues_Y1 204,673,538,610
25 Revenues_Y2 206,067,813,756
26 Revenues_Y3 206,418,451,840
27 Revenues_Y4 206,506,667,494
28 Revenues_Y5 206,528,865,964
29 remainder_NetIncome 0
30 remainder_ComprehensiveNetIncome 690,075,989
  yvar yval
0 Assets 121,494,000,000
1 Liabilities 77,468,000,000
2 Expenses 198,769,459,464
3 Revenues 206,528,865,964
4 StockholdersEquity 44,026,000,000
5 NetIncome 7,759,406,500
6 ComprehensiveNetIncome 8,104,444,494
7 BaseVar 5,002,722,563,008
8 EconomicCapitalRatiobeforeLimitedLiability 0.690
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Company Valuation

Change over Time